Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 05, 2015 7:39 AM ET


Company Overview of Aegera Therapeutics, Inc.

Company Overview

Aegera Therapeutics, Inc. is a clinical-stage biotechnology company that develops therapeutics primarily to address oncology and immuno-inflammation. The company focuses on developing HGS1029 is a small molecule pan-IAP inhibitor for the treatment of a range of cancers; and AEG35156, a second generation antisense oligonucleotide that targets XIAP and is designed to lower the apoptotic threshold of cancer cells. It also focuses on various preclinical stage programs in the areas of oncology, autoimmune/inflammatory, solid tumors, fungal infections, and central nervous system diseases that include small molecule Bruton's tyrosine kinase inhibitors, inhibitor of apoptosis proteins, FMS inhibitor...

810 chemin du Golf

Montreal, QC H3E 1A8


Founded in 1997





Key Executives for Aegera Therapeutics, Inc.

Scientific Founder
Scientific Founder
Scientific Founder
Scientific Founder
Scientific Founder
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Angiogene, Inc. Americas
AbCelex Technologies Inc. Americas
IatroQuest Corporation Americas
Millenium Biologix Corp. Americas
Thallion Pharmaceuticals, Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aegera Therapeutics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at